in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—23 July 2013
9:16 AM MDT | July 23, 2013 | Deepti Ramesh
Albemarle’s fine chemistry business reports lower sales, profits Albemarle says that sales from the company's fine chemistry segment decreased by 15.6% in the second quarter compared with the year-ago period, to $176.1 million, mainly because of lower sales volumes and unfavorable pricing. Profits in the fine chemistry segment decreased 25% in the second quarter, to $34.4 million, because of unfavorable pricing, lower factory operating rates, and the timing of custom services projects, Albemarle says. Pharmaceutical exports rise in...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee